ARTICLE | Clinical News
Oros hydromorphone regulatory update
December 5, 2005 8:00 AM UTC
JNJ subsidiary Alza Corp. (Mountain View, Calif.) said it is considering its options for moving forward with its Oros hydromorphone to manage chronic pain after FDA said an additional trial would be ...